Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma

British Journal of Cancer

Volumn 102, Issue 9, 2010, Pages 1384-1390

  Kontos, C K ^a   Papadopoulos, I N ^b   Fragoulis, E G ^a   Scorilas, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Colorectal adenocarcinoma; DDC; L DOPA decarboxylase; Real time PCR; Tumour biomarkers

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; DISEASE FREE INTERVAL; FEMALE; GENE EXPRESSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOPA DECARBOXYLASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; SURVIVORS;

EID: 77951697276     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605654     Document Type: Article

References (68)

1. Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin JP, Hemminki A, Schwartz Jr S, Aaltonen LA, Arango D (2005) SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 11: 2606-2611
2. Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A (2008) Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer. Clin Biochem 41: 1140-1149
3. Berry MD, Juorio AV, Li XM, Boulton AA (1996) Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res 21: 1075-1087
4. Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C (2002) SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 87: 630-634
5. Bozzi F, Luksch R, Collini P, Gambirasio F, Barzano E, Polastri D, Podda M, Brando B, Fossati-Bellani F (2004) Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma. Diagn Mol Pathol 13: 135-143
6. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259
7. Christenson JG, Dairman W, Udenfriend S (1972) On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine) . Proc Natl Acad Sci USA 69: 343-347
8. Compton CC, Greene FL (2004) The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 54: 295-308
9. Cox DR (1972) Regression models and life tables. R Stat Soc B 34: 187-202
10. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39: 718-727
11. Dukes CE (1932) The classification of cancer of the rectum. J Pathol Bacteriol 35: 323
12. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781
13. Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL, Schuller HM, Park JG (1988) Expression of neuroendocrine cell markers L-Dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res 48: 4078-4082
14. Gilbert J, Haber M, Bordow SB, Marshall GM, Norris MD (1999) Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies. Am J Pathol 155: 17-21
15. Gilbert JA, Bates LA, Ames MM (1995) Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors. Biochem Pharmacol 50: 845-850
16. Gilbert JA, Frederick LM, Ames MM (2000) The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res 6: 4365-4372
17. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401
18. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77
19. Ichinose H, Sumi-Ichinose C, Ohye T, Hagino Y, Fujita K, Nagatsu T (1992) Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic L-amino acid decarboxylase. Biochemistry 31: 11546-11550
20. Ippolito JE, Xu J, Jain S, Moulder K, Mennerick S, Crowley JR, Townsend RR, Gordon JI (2005) An integrated functional genomics and metabo-lomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci USA 102: 9901-9906
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249
22. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213-221
23. Jensen SM, Gazdar AF, Cuttitta F, Russell EK, Linnoila RI (1990) A comparison of synaptophysin, chromogranin, and L-Dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines. Cancer Res 50: 6068-6074
24. Kaplan EL, Meier P (1958) Nonparametric observation from incomplete observations. J Am Stat Assoc 53: 457-481
25. Kokkinou I, Fragoulis EG, Vassilacopoulou D (2009a) The U937 macro-phage cell line expresses enzymatically active L-Dopa decarboxylase. J Neuroimmunol 216: 51-58
26. Kokkinou I, Nikolouzou E, Hatzimanolis A, Fragoulis EG, Vassilacopoulou D (2009b) Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes. Blood Cells Mol Dis 42: 92-98
27. Krieger M, Coge F, Gros F, Thibault J (1991) Different mRNAs code for Dopa decarboxylase in tissues of neuronal and nonneuronal origin. Proc Natl Acad Sci USA 88: 2161-2165
28. Lang PA, Kempe DS, Akel A, Klarl BA, Eisele K, Podolski M, Hermle T, Niemoeller OM, Attanasio P, Huber SM, Wieder T, Lang F, Duranton C (2005) Inhibition of erythrocyte 'apoptosis' by catecholamines. Naunyn Schmiedebergs Arch Pharmacol 372: 228-235
29. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343: 162-168
30. Lindstrom P, Sehlin J (1983) Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase. Endocrinology 112: 1524-1529
31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408
32. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast Jr RC (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327
33. Maneckjee R, Baylin SB (1983) Use of radiolabeled monofluoromethyl-Dopa to define the subunit structure of human L-Dopa decarboxylase. Biochemistry 22: 6058-6063
34. Mappouras DG, Stiakakis J, Fragoulis EG (1990) Purification and characterization of L-Dopa decarboxylase from human kidney. Mol Cell Biochem 94: 147-156
35. Margiotti K, Wafa LA, Cheng H, Novelli G, Nelson CC, Rennie PS (2007) Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-Dopa decarboxylase in human prostate cancer cells. Mol Cancer 6: 38
36. Martinez-Lopez E, Abad A, Font A, Monzo M, Ojanguren I, Pifarre A, Sanchez JJ, Martin C, Rosell R (1998) Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114: 1180-1187
37. McLeod HL, Murray GI (1999) Tumour markers of prognosis in colorectal cancer. Br J Cancer 79: 191-203
38. Medina MA, Quesada AR, Nunez de Castro I, Sanchez-Jimenez F (1999) Histamine, polyamines, and cancer. Biochem Pharmacol 57: 1341-1344
39. Munro AJ, Lain S, Lane DP (2005) P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer 92: 434-444
40. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572-1575
41. O'Malley KL, Harmon S, Moffat M, Uhland-Smith A, Wong S (1995) The human aromatic L-amino acid decarboxylase gene can be alternatively spliced to generate unique protein isoforms. J Neurochem 65: 2409-2416
42. Ogunbiyi OA, Goodfellow PJ, Herfarth K, Gagliardi G, Swanson PE, Birnbaum EH, Read TE, Fleshman JW, Kodner IJ, Moley JF (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16: 427-433
43. Parkin DM, Bray F, Ferlay J, Pisani P (2001a) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156
44. Parkin DM, Bray FI, Devesa SS (2001b) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8): S4-S66
45. Pisani P, Bray F, Parkin DM (2002) Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97: 72-81
46. Pokorny RM, Hunt L, Galandiuk S (2000) What's new with tumor markers for colorectal cancer? Dig Surg 17: 209-215
47. Popat S, Houlston RS (2005) A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41: 2060-2070
48. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618
49. Popat S, Matakidou A, Houlston RS (2004) Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 22: 529-536
50. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 41: 755-760 (Pubitemid 28287548)
51. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23: 7518-7528
52. Sakakura C, Takemura M, Hagiwara A, Shimomura K, Miyagawa K, Nakashima S, Yoshikawa T, Takagi T, Kin S, Nakase Y, Fujiyama J, Hayasizaki Y, Okazaki Y, Yamagishi H (2004) Overexpression of Dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micro-metastases with real-time RT-PCR. Br J Cancer 90: 665-671
53. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele Jr G, Jessup JM, Loda M, Summerhayes IC (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335: 1727-1732
54. Siaterli MZ, Vassilacopoulou D, Fragoulis EG (2003) Cloning and expression of human placental L-Dopa decarboxylase. Neurochem Res 28: 797-803
55. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM (1986) Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 57: 1866-1870
56. Suh KW, Kim JH, Kim YB, Kim J, Jeong S (2005) Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer. J Gastrointest Surg 9: 336-342
57. Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T (1992) Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31: 2229-2238
58. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjold B (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373
59. Tsourouflis G, Theocharis SE, Sampani A, Giagini A, Kostakis A, Kouraklis G (2008) Prognostic and predictive value of thymidylate synthase expression in colon cancer. Dig Dis Sci 53: 1289-1296
60. Uccella S, Cerutti R, Vigetti D, Furlan D, Oldrini R, Carnevali I, Pelosi G, La Rosa S, Passi A, Capella C (2006) Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis. J Histochem Cytochem 54: 863-875
61. van der Schouw YT, Verbeek AL, Wobbes T, Segers MF, Thomas CM (1992) Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. Br J Cancer 66: 148-154
62. Vassilacopoulou D, Sideris DC, Vassiliou AG, Fragoulis EG (2004) Identification and characterization of a novel form of the human L-Dopa decarboxylase mRNA. Neurochem Res 29: 1817-1823
63. Vassiliou AG, Fragoulis EG, Vassilacopoulou D (2009) Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta. Neurochem Res 34: 1089-1100
64. Vassiliou AG, Vassilacopoulou D, Fragoulis EG (2005) Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum. Neurochem Res 30: 641-649
65. Wafa LA, Cheng H, Rao MA, Nelson CC, Cox M, Hirst M, Sadowski I, Rennie PS (2003) Isolation and identification of L-Dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system. Biochem J 375: 373-383
66. Wafa LA, Palmer J, Fazli L, Hurtado-Coll A, Bell RH, Nelson CC, Gleave ME, Cox ME, Rennie PS (2007) Comprehensive expression analysis of L-Dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors. Hum Pathol 38: 161-170
67. Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57: 941-950
68. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499